207 related articles for article (PubMed ID: 17644434)
21. Disposal of plasma heme in normal man and patients with intravascular hemolysis.
Sears DA
J Clin Invest; 1970 Jan; 49(1):5-14. PubMed ID: 4188269
[TBL] [Abstract][Full Text] [Related]
22. The red cell revisited--matters of life and death.
Werre JM; Willekens FL; Bosch FH; de Haans LD; van der Vegt SG; van den Bos AG; Bosman GJ
Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):139-45. PubMed ID: 15095784
[TBL] [Abstract][Full Text] [Related]
23. Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India.
Tripathi K; Kumar R; Bharti K; Kumar P; Shrivastav R; Sundar S; Pai K
Clin Chim Acta; 2008 Feb; 388(1-2):135-8. PubMed ID: 18023276
[TBL] [Abstract][Full Text] [Related]
24. Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans.
Chava AK; Chatterjee M; Sharma V; Sundar S; Mandal C
J Infect Dis; 2004 Apr; 189(7):1257-64. PubMed ID: 15031795
[TBL] [Abstract][Full Text] [Related]
25. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
26. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis F; Sundar S; Hailu A; Ghalib H; Rijal S; Peeling RW; Alvar J; Boelaert M
Nat Rev Microbiol; 2007 Nov; 5(11):873-82. PubMed ID: 17938629
[TBL] [Abstract][Full Text] [Related]
27. Designing and testing of an effective oil-in-water microemulsion drug delivery system for in vivo application.
Gupta S; Moulik SP; Lala S; Basu MK; Sanyal SK; Datta S
Drug Deliv; 2005; 12(5):267-73. PubMed ID: 16188725
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
Bhardwaj S; Vasishta RK; Arora SK
Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
[TBL] [Abstract][Full Text] [Related]
29. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
30. Influence of dietary quercetin on glutathione redox status in mice.
Meyers KJ; Rudolf JL; Mitchell AE
J Agric Food Chem; 2008 Feb; 56(3):830-6. PubMed ID: 18198829
[TBL] [Abstract][Full Text] [Related]
31. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
33. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
Bhowmick S; Ravindran R; Ali N
Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
[TBL] [Abstract][Full Text] [Related]
34. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?
Weisser M; Khanlari B; Terracciano L; Arber C; Gratwohl A; Bassetti S; Hatz C; Battegay M; Flückiger U
Clin Microbiol Infect; 2007 Aug; 13(8):751-3. PubMed ID: 17610597
[TBL] [Abstract][Full Text] [Related]
35. Covalent binding of the flavonoid quercetin to human serum albumin.
Kaldas MI; Walle UK; van der Woude H; McMillan JM; Walle T
J Agric Food Chem; 2005 May; 53(10):4194-7. PubMed ID: 15884859
[TBL] [Abstract][Full Text] [Related]
36. Altered calcium homeostasis and membrane destabilization in erythrocytes of hamsters infected with Leishmania donovani.
Sen G; Ghosal J; Naskar K; Biswas T
Ann Trop Med Parasitol; 2000 Jan; 94(1):43-53. PubMed ID: 10723523
[TBL] [Abstract][Full Text] [Related]
37. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
[TBL] [Abstract][Full Text] [Related]
38. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
[TBL] [Abstract][Full Text] [Related]
39. Visceral leishmaniasis with aplastic bonemarrow: coincidental or causal.
Srinivas U; Kar R; Prem S; Mahapatra M; Pati HP
Scand J Infect Dis; 2007; 39(3):261-2. PubMed ID: 17366060
[TBL] [Abstract][Full Text] [Related]
40. In vivo effect of zinc on iron turnover in rats and life span of the erythrocyte.
Ettlemire CT; Matrone G
J Nutr; 1967 Jun; 92(2):159-64. PubMed ID: 6029067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
